Medicare Enrolled
Dr. Julia Schaefer-Cutillo, M.D.
Hematology & Oncology · Elizabeth City, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schaefer-Cutillo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schaefer-Cutillo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schaefer-Cutillo
Dr. Julia Schaefer-Cutillo is a hematology & oncology specialist in Elizabeth City, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Schaefer-Cutillo performed 382,960 Medicare services across 8,404 unique beneficiaries.
Between the years covered by Open Payments, Dr. Schaefer-Cutillo received a total of $1,038 from 24 pharmaceutical and/or device companies across 51 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schaefer-Cutillo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in NC
$1,038 industry payments
Medicare Practice Summary
Medicare Utilization ↗382,960
Medicare services
Top 0% in NC for hematology & oncology
8,404
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~20,156 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
60,240 | $2 | $21 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
56,610 | $0 | $6 |
| Pembrolizumab injection (Keytruda) | 55,000 | $43 | $147 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
35,700 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 29,900 | $1 | $9 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
28,500 | $0 | $20 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
20,640 | $0 | $36 |
| Denosumab injection (Prolia/Xgeva) | 16,320 | $18 | $70 |
| Nivolumab injection (Opdivo) | 16,080 | $24 | $81 |
| Paclitaxel chemotherapy injection | 9,828 | $0 | $17 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
9,450 | $0 | $6 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,982 | $0 | $1 |
| Injection, docetaxel, 1 mg | 4,576 | $1 | $71 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,390 | $1 | $122 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
3,042 | $10 | $62 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
2,580 | $6 | $55 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,663 | $11 | $105 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,253 | $10 | $93 |
| Injection, granisetron hydrochloride, 100 mcg | 1,180 | $0 | $25 |
| Iron dextran injection, 50 mg An injection containing 50 mg of iron dextran administered to the patient. |
1,080 | $13 | $78 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,016 | $91 | $302 |
| Anti-nausea injection (ondansetron/Zofran) | 992 | $0 | $3 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
960 | $81 | $1,444 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
940 | $13 | $58 |
| Iron level test | 934 | $6 | $26 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
934 | $9 | $34 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
933 | $2 | $35 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
913 | $95 | $834 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
821 | $18 | $175 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
804 | $9 | $54 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
772 | $61 | $181 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
700 | $95 | $879 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
655 | $2 | $300 |
| Immunoassay substance measurement A laboratory test that uses immunoassay techniques to measure the level of a specific substance in a sample. |
584 | $17 | $181 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
542 | $15 | $74 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
531 | $14 | $71 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
486 | $16 | $78 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
421 | $2 | $94 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
415 | $6 | $30 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
390 | $1 | $19 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
386 | $9 | $63 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
338 | $45 | $304 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
325 | $11 | $96 |
| Serum immunofixation test A laboratory test that analyzes a blood serum sample to identify specific abnormal proteins. The procedure uses an immunologic technique to detect and characterize these proteins. |
325 | $22 | $155 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
297 | $48 | $407 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 292 | $20 | $124 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
261 | $89 | $294 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
252 | $21 | $189 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
233 | $127 | $379 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
222 | $21 | $152 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
198 | $1 | $6 |
| Injection, leucovorin calcium, per 50 mg | 187 | $3 | $27 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
181 | $1 | $4 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
178 | $51 | $249 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
178 | $2 | $19 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
177 | $19 | $96 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
177 | $7 | $462 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
163 | $23 | $249 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
123 | $73 | $70 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
105 | $7 | $35 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
99 | $177 | $986 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 96 | $132 | $3,938 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
95 | $15 | $97 |
| PSA test (prostate cancer screening) | 93 | $18 | $91 |
| New patient office visit, complex (60-74 min) | 81 | $166 | $580 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
80 | $38 | $102 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
69 | $29 | $243 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
69 | $22 | $172 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
69 | $41 | $343 |
| Haptoglobin level test A blood test that measures the amount of haptoglobin, a protein in the serum. It helps evaluate red blood cell breakdown. |
60 | $12 | $64 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
57 | $8 | $19 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
57 | $13 | $96 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
55 | $1 | $19 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
54 | $81 | $267 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
51 | $4 | $24 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
51 | $9 | $73 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
50 | $61 | $204 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
48 | $62 | $168 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $119 | $461 |
| CA 19-9 tumor antigen test A blood test that measures the level of CA 19-9, a substance that can be found in the blood of some people with cancer. This quantitative analysis detects and measures the specific tumor antigen. |
45 | $20 | $124 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
41 | $97 | $243 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
34 | $5 | $23 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
33 | $59 | $289 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
33 | $59 | $251 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
30 | $1 | $9 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
27 | $7 | $28 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
25 | $16 | $93 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
23 | $27 | $240 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $99 | $297 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
12 | $128 | $523 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.4% high complexity
80.7% medium
4.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,038
Total received (2018-2024)
Avg $173/year across 6 years
Bottom 39% in NC for hematology & oncology
24
Companies
51
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$629 (60.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$408 (39.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$20
2022
$17
2021
$12
2020
$161
2019
$705
2018
$124
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PUMA BIOTECHNOLOGY, INC.
$20
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$218
Janssen Biotech, Inc.
$159
Amgen Inc.
$86
PFIZER INC.
$64
E.R. Squibb & Sons, L.L.C.
$56
Ipsen Biopharmaceuticals, Inc
$46
Novartis Pharmaceuticals Corporation
$44
AstraZeneca Pharmaceuticals LP
$44
Merck Sharp & Dohme Corporation
$37
Bayer HealthCare Pharmaceuticals Inc.
$28
Incyte Corporation
$27
Celgene Corporation
$22
Clovis Oncology, Inc.
$22
Eisai Inc.
$20
JAZZ PHARMACEUTICALS INC.
$20
PUMA BIOTECHNOLOGY, INC.
$20
Seagen Inc.
$19
EMD Serono, Inc.
$18
GE HealthCare
$17
Alexion Pharmaceuticals, Inc.
$16
Seattle Genetics, Inc.
$15
Daiichi Sankyo Inc.
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Gilead Sciences, Inc.
$12
Top 3 companies account for 44.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Alecensa · Balversa · Bavencio · DARZALEX · ELIQUIS · Enhertu · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · Lenvima · Neulasta · Nplate · OPDIVO · PIQRAY · Perjeta · Revlimid · Rubraca · SOMATULINE DEPOT · Somatuline Depot · TECENTRIQ · ULTOMIRIS · VYXEOS · Vitrakvi · Xofigo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (61%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
3
Per 100K population
7.3
County median income
$63,912
Nearest hospital
SENTARA ALBEMARLE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Schaefer-Cutillo is a mixed practice specialist, with above-average Medicare volume (top 0% in NC), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Schaefer-Cutillo experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Schaefer-Cutillo performed 60,240 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schaefer-Cutillo receive payments from pharmaceutical companies?
Yes. Dr. Schaefer-Cutillo received a total of $1,038 from 24 companies across 51 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schaefer-Cutillo's costs compare to other hematology & oncology specialists in Elizabeth City?
Dr. Schaefer-Cutillo's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schaefer-Cutillo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Elizabeth City
Browse hematology & oncology specialists in Elizabeth City ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NC
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NC
Which NC hematology & oncology specialists receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology